Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Pharmaceutical Computer Systems Validation -

Pharmaceutical Computer Systems Validation

Quality Assurance, Risk Management and Regulatory Compliance, Volume 1

Guy Wingate (Herausgeber)

Buch | Hardcover
440 Seiten
2026 | 3rd edition
CRC Press (Verlag)
9781032981086 (ISBN)
CHF 329,95 inkl. MwSt
  • Noch nicht erschienen (ca. Mai 2026)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This new edition deals with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a walk-through of lifecycle and development methodologies, and the second volume comprises a set of refreshed case studies spanning laboratory, manufacturing and supply chain systems.
Computerised systems play a fundamental role in the development, manufacture and supply of medical treatments. This is the third and thoroughly updated edition of the best-selling book dealing with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a comprehensive walk-through of lifecycle and development methodologies bringing together technological advances, latest regulatory requirements, inspection findings, and compliance strategies. New chapters have been added on agile development methodologies, data integrity, artificial intelligence and machine learning. The second volume comprises an extensive set of refreshed case studies spanning laboratory, manufacturing and supply chain systems with new contributions on databases, spreadsheets, LIMS, blockchain, mobile devices, AI-enabled systems, big data and digital twins authored by various industry experts.

Key Features



Covers organizational responsibilities, project lifecycle, operational compliance, risk management, data integrity, practical trouble shooting, handling regulatory inspections, metrics and the opportunity for performance improvement.
Includes 20 new and updated case studies by industry experts, demonstrating how these computer system validation principles are put into practice.
Discusses industry regulations and guidance including current thinking of US FDA on computer software assurance, the latest guidance from US FDA/EU/MHRA on data integrity and newly published ISPE GAMP 5 Guide (Second Edition).
Focuses on regulatory requirements covering GCPs, GLPs, GMPs and GDPs – complete with observations from inspections by US FDA and other regulators
Includes new material dealing with the latest advancements concerning data integrity, machine-learning and artificial intelligence, data-lakes, cloud computing services, mobile devices, and IT tools.

Guy Wingate, PhD, was Vice-President of Compliance at GlaxoSmithKline until his recent retirement. A well-known speaker on computer validation, Dr Wingate has over 30 years’ experience in the pharmaceutical industry. He has been a visiting lecturer at the University of Manchester’s M.Sc. Pharmaceutical Engineering Advanced Training program and Dublin Institute of Technology’s accredited M.Sc. Validation Science program. Dr Wingate is an active member of the ISPE and was chair of the GAMP Council for 10 years which is responsible for the internationally recognized suite of GAMP Guides on computer compliance. Dr Wingate’s extensive list of published work includes the books Validating Corporate Computer Systems and previous editions of this book Pharmaceutical Computer Systems Validation.

Foreword. Preface. About The Editor. Abbreviations. Chapter 1 Introduction. Chapter 2 Organization and Management. Chapter 3 Lifecycle Methodologies & Supporting Processes. Chapter 4 Prospective Verification and Validation. Chapter 5 Project Initiation and Compliance Determination. Chapter 6 Requirements Capture and Supplier (Vendor) Selection. Chapter 7 Design and Development. Chapter 8 Coding, Configuration, and Build. Chapter 9 Development Testing. Chapter 10 User Qualification and Authorization to Use. Chapter 11 Operation and Maintenance. Chapter 12 Phaseout and Withdrawal. Chapter 13 Data Integrity. Chapter 14 Regulated Electronic Records and Electronic Signatures. Chapter 15 Artificial Intelligence & Machine Learning. Chapter 16 Regulatory Inspections. Chapter 17 Compliance Strategies. Chapter 18 Capabilities, Measures, and Performance. Chapter 19 Practical Troubleshooting. Chapter 20 Concluding Remarks. Glossary. Index

Erscheint lt. Verlag 26.5.2026
Reihe/Serie Drugs and the Pharmaceutical Sciences
Zusatzinfo 49 Tables, black and white; 1 Line drawings, color; 122 Line drawings, black and white; 1 Illustrations, color; 122 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Laboratoriumsmedizin
Naturwissenschaften Biologie
Technik
ISBN-13 9781032981086 / 9781032981086
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Arno J. Dormann; Christian Heer; Fabian Wisplinghoff

Buch | Softcover (2025)
Urban & Fischer in Elsevier (Verlag)
CHF 32,15
mit Zytologieatlas

von Uwe K. Zettl; Hayrettin Tumani; Sigurd Dietrich Süßmuth

Buch | Hardcover (2025)
De Gruyter (Verlag)
CHF 244,90